Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details)

v3.24.2
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 18,747,581 18,211,237
Stock Options    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 1,533,059 1,747,357
Unvested Restricted Stock Units    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 3,072,224 2,321,582
Warrants    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 14,142,298 14,142,298